Rapport Therapeutics Inc....

9.06
1.91 (26.71%)
At close: Mar 04, 2025, 1:08 PM

Rapport Therapeutics Common Stock Balance Sheet Statement

Year FY23 FY22
Cash & Equivalents 70.17M 31.16M
Short-Term Investments 77.31M n/a
Long-Term Investments n/a n/a
Other Long-Term Assets 551K n/a
Receivables n/a n/a
Inventory n/a n/a
Other Current Assets 3.31M 109K
Total Current Assets 150.87M 31.27M
Property-Plant & Equipment 4M 335K
Goodwill & Intangibles n/a n/a
Total Long-Term Assets 4.55M 335K
Total Assets 155.42M 31.6M
Account Payables 2.5M 1.45M
Deferred Revenue n/a n/a
Short-Term Debt 670K n/a
Other Current Liabilities 5.63M 213K
Total Current Liabilities 8.8M 1.66M
Long-Term Debt 1.48M n/a
Other Long-Term Liabilities 4.2M 10.44M
Total Long-Term Liabilities 5.68M 10.44M
Total Liabilities 14.48M 12.1M
Total Debt 2.15M n/a
Common Stock 4K 31K
Retained Earnings -45.44M -10.65M
Comprehensive Income 4K -31K
Shareholders Equity 140.94M 19.5M
Total Investments 77.31M n/a